Therapeutic use and profile of toxicity of the FOLFOX4 regimen;Uso terapéutico y perfil de toxicidad del esquema FOLFOX4

Farmacia Hospitalaria

Volumn 33, Issue 2, 2009, Pages 89-95

  Fernandez Lobato B ^a   Diaz Carrasco M S ^a   Pareja, A ^a   Marin M ^a   Vila, N ^a   De La Rubia, A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

FOLFOX4; Toxicity; Usage study

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGE; AGED; ARTICLE; ASTHENIA; CANCER STAGING; CLINICAL ARTICLE; COLON CANCER; COLORECTAL CANCER; DIARRHEA; FEMALE; GENDER; HEMOGLOBINOPATHY; HUMAN; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PERIPHERAL NEUROPATHY; RECTUM CANCER; STOMACH CANCER; THROMBOCYTOPENIA; URINARY TRACT INFECTION; VOMITING;

EID: 68349101210     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(09)70993-6     Document Type: Editorial

References (43)

1. J. Ferlay, F. Bray, P. Pisani, and D.M. Parkin GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide 10th ed. 2001 IARC Press Lyon
2. La situación del Cáncer en España. Ministerio de Sanidad y Consumo, 2005 [citado, 20 Jun 2008] Disponible en: http://www.isciii.es/htdocs/centros/epidemiologia/epi-cancer.jsp
3. Colon and rectum. En: American Joint Committeé on Cancer. AJCC cancer staging manual. 5th ed. Philadedlphia: Lippincott-Raven; 1997. p. 83-90.
4. American Cancer Society. Colon and rectum cancer [citado, 20 Jun 2008]. Disponible en: http://www.cancer.org/docroot/CRI/content/CRI-2-4-3X-How-is- colon-and-rectum-cancer-staged.asp
5. J.A. Meyerhardt, and R.J. Mayer Systemic therapy for colorectal cancer N Engl J Med 352 2005 476 487
6. Meta-Analysis Group in Cancer Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis J Clin Oncol 22 2004 3766 3775
7. Meta-Analysis Group in Cancer Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer J Clin Oncol 16 1998 301 308
8. E. Van Cutsem, C. Twelves, J. Cassidy, D. Allman, E. Bajetta, and M. Boyer Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study J Clin Oncol 19 2001 4097 4106
9. P.M. Hoff, R. Ansari, G. Batist, J. Cox, W. Kocha, and M. Kuperminc Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study J Clin Oncol 19 2001 2282 2292
10. G. Folprecht, and C.H. Köhne The role of new agents in the treatment of colorectal cancer Oncology 66 2004 1 17 (Pubitemid 38410674)
11. L.B. Saltz, J.V. Cox, C. Blanke, L.S. Rosen, L. Fehrenbacher, and M.J. Moore Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group N Engl J Med 343 2000 905 914
12. T. Andre, C. Louvet, F. Maindrault-Goebel, C. Couteau, M. Mabro, and J.P. Lotz CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR Eur J Cancer 35 1999 1343 1347
13. J.Y. Douillard, D. Cunningham, A.D. Roth, M. Navarro, R.D. James, and P. Karasek Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial Lancet 355 2000 1041 1047
14. C.H. Kohne, E. van Cutsem, J. Wils, C. Bokemeyer, M. El-Serafi, and M.P. Lutz Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986 J Clin Oncol 23 2005 4856 4865
15. A. De Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, and J. Cassidy Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2000 2938 2947
16. G. Colucci, V. Gebbia, G. Paoletti, F. Giuliani, M. Caruso, and N. Gebbia Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: A multicenter study of the Gruppo Oncologico Dell'Italia Meridionale J Clin Oncol 23 2005 4866 4875
17. R. Goldberg, D. Sargent, R. Morton, C. Fuchs, R. Ramanathan, and S. Williamson A randomized controlled trial of fluorouracil plus leucovorin, irinotecan and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 2004 23 30
18. C. Tournigand, T. Andre, E. Achille, G. Lledo, M. Flesh, and D. Mery-Mignard FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study J Clin Oncol 22 2004 229 237
19. R. Díez-Fernández, P. Salinas, and C. Girón-Duch Revisión del tratamiento quimioterápico del cáncer de colon metastático Farm Hosp 30 2006 359 369
20. National Comprehensive Cancer Network: Practice Guidelines in Oncology, Colon Cancer [citado, 20 Jun 2008]. Disponible en: http://www.nccn.org/ professionals/physician-gls/PDF/colon.pdf
21. The role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first and second-line treatment of advanced colorectal cancer: A clinical practice guideline [citado, 20 Jun 2008] Disponible en: http://www.cancercare. on.ca/english/toolbox/drugs/drugformulary/drugregimens/gastro/#coloadv
22. ® ). National Cancer Institute [citado, 20 Jun 2008]. Disponible en: http://www.cancer.gov/cancertopics/pdq/ treatment/colon/HealthProfessional/page10
23. A. Grothey, D. Sargent, R.M. Goldberg, and H.J. Schmoll Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan and oxaliplatin in the course of treatment J Clin Oncol 22 2004 1209 1214
24. C.G. Moertel, T.R. Fleming, J.S. Macdonald, D.G. Haller, J.A. Laurie, and P.J. Goodman Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322 1990 352 358
25. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet. 1995;345:939-44.
26. N. Wolmark, H. Rockette, E. Mamounas, J. Jones, S. Wieand, and D.L. Wickerham Clinical trial to assess the relative efficacy of fluorouracil and lecovorin, fluorouracil and levamisol, and fluorouracil, leucovorin, and levamisol in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project protocol C-04 J Clin Oncol 17 1999 3553 3559
27. L.B. Saltz, D. Niedzwiecki, D. Hollis, R.M. Goldberg, A. Hantel, and J.P. Thomas Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803 J Clin Oncol 25 2007 3456 3461
28. T. André, C. Boni, L. Mounedji-Boudiaf, M. Navarro, J. Tabernero, and T. Hickish Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343 2351
29. National Cancer Institute Common Toxicity Criteria version 2.0 [citado, 20 Jun 2008] Disponible en: http://ctep.cancer.gov/forms/CTCv20-4-30-992.pdf
30. A. de Gramont, C. Boni, M. Navarro, J. Tabernero, T. Hickish, and C. Topham Oxaliplatin/5FU/LV in adjuvant colon cancer: updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years J Clin Oncol 25 Suppl 20 2007 abstract 4007
31. Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: Guideline Recommendations-citado, 20 Jun 2008-. Disponible en: http://www.cancercare.on.ca/english/toolbox/drugs/drugformulary/ drugregimens/gastro/#coloadj
32. R. Gray, J. Barnwell, C. McConkey, Rk. Hills, N.S. Williams, D.J. Kerr Quasar Collaborative Group Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study Lancet 370 2007 2020 2029
33. E. Mamounas, S. Wieand, N. Wolmark, H.D. Bear, J.N. Atkins, and K. Song Comparative efficacy of adjuvant chemotherapy in patients with Duke's B versus Duke's C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies (C-01, C-02, C-03 and C-04) J Clin Oncol 17 1999 1349 1355
34. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) investigators Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer J Clin Oncol 17 1999 1356 1363
35. S. Gill, C.L. Loprinzi, D.J. Sargent, S.D. Thomé, S.R. Alberts, and D.G. Haller Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22 2004 1797 1806
36. O. Aranha, and A.B. Benson 3rd Adjuvant therapy for colon cancer Curr Gastroenterol Rep 9 2007 415 421
37. E. Aranda, A. Abad, A. Carrato, A. Cervantes, J. Tabernero, E. Díaz-Rubio TTD Group (Spanish Cooperative Group for Gastrointestinal Tumor Theraphy) Guides for adjuvant treatment of colon cancer Clin Transl Oncol 8 2006 98 102
38. L. Cavanna, F. Artioli, C. Codignola, A. Lazzaro, A. Rizzi, and A. Gamboni Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC) Am J Clin Oncol 29 2006 371 375
39. S.W. Siu, R.T. Chan, and G.K. Au Hypersensitivity reactions to oxaliplatin: experience in a single institute Ann Oncol 17 2006 259 261
40. J. Cassidy, S. Clarke, E. Díaz-Rubio, W. Scheithauer, A. Figer, and R. Wong Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer J Clin Oncol 26 2008 2006 2012
41. nd -line treatment for patients with metastatic colorectal cancer (MCRC) J Clin Oncol (Meeting Abstracts) 25 2007 4031
42. C. Twelves, A. Wong, M.P. Nowacki, M. Abt, H. Burris 3rd, and A. Carrato Capecitabine as adjuvant treatment for stage III colon cancer N Engl J Med 352 2005 2696 2704
43. H.J. Schmoll, T. Cartwright, J. Tabernero, M.P. Nowachi, A. Figer, and J. Maroun Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients J Clin Oncol 25 2007 102 109